参考文献/References:
[1] Montalban X,Gold R,Thompson AJ,et al.ECTRIMS/EAN guideline on the pharmacological treatment of People with multiple sclerosis[J].European Journal of Neurology,2018,25(2):215-237.
[2] Ferret-Sena VC,Capela,Sena A.Metabolic dysfunction and peroxisome proliferator-activated receptors(PPAR)in multiple sclerosis[J].Int J Mol Sci,2018,19(6):1639-1663.
[3] Franklin RJ,Kotter MR.The biology of CNS remyelination:the key to therapeutic advances[Z],2008:19-25.
[4] Murtie JC,Zhou YX,Le TQ,et al.PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination[J].Neurobiol Dis,2005,19(1/2):171-182.
[5] Adriana,Octaviana,Dulamea.The contribution of oligodendrocytes and oligodendrocyte progenitor cells to central nervous system repair in multiple sclerosis: perspectives for remyelination therapeutic strategies[J].Neural Regeneration Research,2017,12(12):1939-1944.
[6] Skaper,D S.Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases[Z],2019:119-144.
[7] Fancy,P S.Myelin regeneration:a recapitulation of development?[Z].Annu Rev Neurosci,2011:21-43.
[8] Yeung MSY,Djelloul M,Steiner E,et al.Dynamics of oligodendrocyte Generation in multiple sclerosis[J].Nature,2019,566(7745):538-542.
[9] Mendiola AS,Cardona AE.The IL-1β phenomena in neuroinflammatory diseases[J].J Neural Transm,2018,125(5):781-795.
[10] Lin CC,Edelson BT.New insights into the role of IL-1β in experimental autoimmune encephalomyelitis and multiple sclerosis[J].J Immunol,2017,198(12):4553-4560.
[11] Mason JL,Suzuki K,Chaplin DD,et al.Interleukin-1beta promotes repair of the CNS[J].J Neurosci,2001,21(18):7046-7052.
[12] Zhang Y,Taveggia C,Melendez-Vasquez C,et al.Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation[J].J Neurosci,2006,26(47):12174-12185.
[13] Madsen PM,Motti D,Karmally S,et al.Oligodendroglial TNFR2 mediates membrane TNF-Dependent repair in experimental autoimmune encephalomyelitis by promoting oligodendrocyte differentiation and remyelination[J].J Neurosci,2016,36(18):5128-5143.
[14] Arnett HA,Mason J,Marino M,et al.TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination[J].Nat Neurosci,2001,4(11):1116-1122.
[15] Caminero AC,X.Montalban,tumor necrosis factor alpha(TNF-alpha),anti-TNF-alpha and demyelination revisited:an ongoing story[J].J Neuroimmunol,2011,234(1/2):1-6.
[16] Hagman,S.Effects of inflammatory cytokines IFN-gamma,TNF-alpha and IL-6 on the viability and functionality of human pluripotent stem cell-derived neural cells[Z],2019:36-45.
[17] Nageeb RS,A.Fawzy,serum insulin-like growth factor 1(IGF-1)in multiple sclerosis:relation to cognitive impairment and fatigue[J].Egypt J Neurol Psychiatr Neurosurg,2018,54(1):25.
[18] Skihar V,Silva C,Chojnacki A,et al.Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate[J].Proc Natl Acad Sci U S A,2009,106(42):17992-17997.
[19] Shahbazi,M.Novel functional polymorphism in IGF-1 gene associated with multiple sclerosis:A new insight to MS[Z],2017:33-37.
[20] Hlavica,M.Intrathecal insulin-like growth factor 1 but not insulin enhances myelin repair in young and aged rats[Z],2017:41-46.
[21] Henrique D,Schweisguth F.Mechanisms of notch signaling: a simple logic deployed in time and space[J].Development,2019,146(3):dev172148.
[22] Bassil RO,W.Elyaman,notch signaling and t-helper cells in EAE/MS[Z],2013:570731.
[23] Jurynczyk M,Jurewicz A,Bielecki B,et al.Inhibition of notch signaling enhances tissue repair in an animal model of multiple sclerosis[J].J Neuroimmunol,2005,170(1/2):3-10.
[24] Aparicio E,Mathieu P,Pereira Luppi M,et al.The notch signaling pathway: its role in focal CNS demyelination and apotransferrin-induced remyelination[J].J Neurochem,2013,127(6):819-836.
[25] Eixarch,H.Bone morphogenetic proteins in multiple sclerosis:Role in neuroinflammation[Z],2018:1-10.
[26] Grinspan,B J.Bone morphogenetic proteins:inhibitors of myelination in development and disease[Z],2015:195-222.
[27] Harnisch K,Teuber-Hanselmann S,Macha N,et al.Myelination in multiple sclerosis lesions is associated with regulation of bone morphogenetic protein 4 and its antagonist noggin[J].Int J Mol Sci,2019,20(1):154-166.
[28] Fuller ML,Dechant AK,Rothstein B,et al.Bone morphogenetic proteins promote gliosis in demyelinating spinal cord lesions[J].Ann Neurol,2007,62(3):288-300.
[29] Vallée A,Vallée JN,Guillevin R,et al.Interactions between the canonical WNT/Beta-Catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis[J].Cell Mol Neurobiol,2018,38(4):783-795.
[30] Hammond E,Lang J,Maeda Y,et al.The Wnt effector transcription factor 7-Like 2 positively regulates oligodendrocyte differentiation in a manner Independent of Wnt/beta-Catenin signaling[J].Journal of Neuroscience,2015,35(12):5007-5022.